UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | C000000400 |
|---|---|
| Receipt number | R000000460 |
| Scientific Title | Phase 2 study of G-CSF priming chemotherapy for high risk myelodysplastic syndrome (MDS) and MDS/secondary AML |
| Date of disclosure of the study information | 2006/04/17 |
| Last modified on | 2018/10/04 18:07:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2006/04/08 16:11:30 | ||
| 2 | Update | 2011/09/09 10:09:53 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
| 3 | Update | 2011/09/09 10:10:17 | Recruitment status |
|
| 4 | Update | 2018/10/04 18:07:25 | Recruitment status Anticipated trial start date |
